Does changing insulin affect life insurance eligibility in Canada?

A recent insulin change temporarily shifts the coverage picture for applicants with early-onset diabetes, but does not prevent access to coverage. Both term and permanent life insurance typically remain available. Coverage amounts may be more conservative for the period following the change, and a partial deferral may apply on some products. Once insulin has been stable for over 12 months, the picture typically improves toward the standard outcome for a well-managed diabetic. A licensed advisor can assess the specific situation.

What is early-onset diabetes for life insurance purposes?

In the simplified issue market, early-onset diabetes typically refers to a diagnosis made at age 39 or under. This places the applicant under a specific question that captures both the early diagnosis and any recent insulin changes. The early-onset question applies regardless of the applicant's current age, someone diagnosed at 28 who is now 45 is still assessed under the early-onset category if insulin has changed recently.

Should someone with early-onset diabetes apply now or wait for insulin to stabilise?

The answer depends on the coverage need and how recently the insulin change occurred. Both term and permanent coverage are available now, but coverage amounts may be more conservative. If the change was recent and the coverage need is not urgent, waiting for stability typically produces better terms. If there is a genuine coverage need now, applying under the current structure secures accidental death protection and starts the clock. A licensed advisor can work through the specific situation.

Condition Guide · Diabetes Series · Part 3 of 4

Early-Onset Diabetes and Life Insurance: When an Insulin Change Affects Your Options

Q: How long after an insulin change can I apply for better life insurance terms?

Carriers typically look at the last 12 months for insulin changes. Once insulin has been stable for over 12 months with no dosage adjustments or new prescriptions, the early-onset insulin trigger resolves and the picture moves toward the standard outcome for a well-managed diabetic. The exact timing varies by carrier, and a licensed advisor can confirm when the right window opens.

A recent insulin change shifts the picture, but not as much as most people expect. Both term and permanent coverage typically remain accessible, and the clock that matters is shorter than it sounds. when to time your application

Claire Haddon Senior Editor, KnowYourPolicy.ca

May 23, 2026 · 6 min read Reviewed by a licensed Canadian insurance professional

The information on this page describes how Canadian life insurers generally assess this condition. It is not a coverage assessment for your specific situation. Eligibility depends on your individual health history, the insurer's current underwriting guidelines, and the type of policy you apply for. A licensed advisor can give you an accurate picture.

Someone was diagnosed with type 1 diabetes at 24. They are now 38, managing well, with a long stable history behind them. Six months ago their endocrinologist adjusted their basal insulin dose. They've been meaning to get life insurance sorted, assumed the change would complicate things, and have been putting it off.

The assumption is more pessimistic than the reality. A recent insulin change does shift the simplified issue picture for someone with an early-onset diagnosis, but it does not close the door on meaningful coverage. Both term and permanent options typically remain available. The shift is in coverage amounts and structure, not in access itself, and it resolves once the insulin has been stable long enough.

What the Early-Onset Insulin Trigger Captures

The simplified issue question set looks at two things separately for this population: whether diabetes was diagnosed at age 39 or under, and whether insulin has been taken, prescribed, or adjusted in the last 12 months. Both conditions together place an applicant in a specific category that is distinct from the standard adult diabetic picture in Part 1.

The early-onset category applies based on diagnosis age, not current age. Someone diagnosed at 28 who is now 45 is still assessed under the early-onset question if insulin has changed recently. The diagnosis date is fixed. What changes over time is the insulin stability picture, and that is the clock this article is about.

It is worth being clear about what a recent insulin change actually means in this context. It includes a dosage adjustment, a switch between insulin types, a new insulin prescription, or the addition of insulin where there was none before. It does not include stable ongoing use with no changes. Someone who has been on the same insulin regimen for two years has no recent change to disclose, regardless of when they were diagnosed.

The most common misconception here is that any insulin use at all produces the restricted outcome. It doesn't. Long-term, stable insulin use with no recent adjustments is assessed as part of the overall stability picture. The trigger is the change, not the presence of insulin.

What Coverage Looks Like With a Recent Change

Within 12 months of an insulin adjustment, both term and permanent coverage are typically still available in the simplified issue market. The difference from the standard outcome is in coverage amounts and structure. Coverage maximums are more conservative than what a stable applicant would access, and some carriers may apply a partial deferral on the non-accidental death benefit for permanent products.

This is not the same as the complications outcome in Part 4. The complications outcome is permanent and has no time window. The recent insulin change outcome is temporary and has a clear clock. Once insulin has been stable for over 12 months, the early-onset insulin trigger resolves and the picture typically moves toward the standard simplified issue outcome for a well-managed adult diabetic.

For an applicant who had an insulin change eight months ago, that means four months until the trigger potentially clears. Whether to apply now under the current structure or wait for the window to close is a timing question a licensed advisor can help work through before anything is submitted.

The Clock and Its Complications

Twelve months of stable insulin is the general threshold. But the clock has one important caveat: it only runs if nothing changes. A second adjustment before the 12 months are up resets the window. A new insulin type, a dosage change in response to an A1C reading, or any prescription modification starts the clock again from that date.

For someone whose insulin tends to be adjusted frequently as part of active management, the 12-month stability window may be harder to reach than it sounds. This is worth knowing before deciding to wait. A licensed advisor who understands the question set can identify whether the current trajectory is likely to produce a clean 12-month window or whether applying now under the current structure makes more practical sense.

As with any medication change and insurance, this should never become a reason to defer a clinically indicated adjustment. If the insulin needs changing, change it. The insurance picture adapts to the health picture, not the other way around. A temporary restriction from a recent change is a better outcome than a permanent one from a complication that developed because management was compromised.

How This Differs From the Under-30 Picture

Part 2 of this series covers the situation where age itself is the restricting factor. This article covers a different population: people who are past the age threshold but whose early diagnosis date keeps the early-onset question in play when insulin changes.

The key distinction is that the under-30 restriction lifts automatically with age. The early-onset insulin restriction lifts with time and stability. One is a calendar, the other is a behaviour. Someone at 38 with a recent insulin change has a clear path to better terms by waiting for stability. Someone at 26 cannot accelerate their birthday.

Both are temporary. Both resolve. But the paths are different, and understanding which situation applies matters before deciding on timing.

Diet and Lifestyle Management

For applicants whose diabetes is managed through diet and lifestyle alone, without insulin or medication, and who have been stable in that approach for a meaningful period, the picture may sit more favourably in some carrier question sets. The absence of insulin altogether, combined with documented stable management, can open better rate categories with certain carriers.

This is not universal across the simplified issue market, and it is not a reason to pursue a non-insulin approach for insurance purposes. If insulin is part of the clinically appropriate management plan, it should remain so. But for applicants who genuinely manage without insulin and have done so consistently, it is worth asking a licensed advisor whether that approach accesses better terms with specific carriers.

What to Bring to the Conversation

Know the diagnosis date and age at diagnosis. Know the current insulin regimen and the date of the most recent change. Know whether that change was a dosage adjustment, a new prescription, or a switch between types. That information tells a licensed advisor exactly where the clock stands and which carriers and products are the right fit for the current picture.

Know the monthly premium that is genuinely comfortable long term and the obligations a death would leave behind. Coverage amount follows from that picture. For many people in this situation, meaningful coverage is accessible right now, and the 12-month clock to better terms is closer than it seemed before this conversation started.

This article is for educational purposes only and does not constitute insurance advice. Eligibility, premiums, and coverage terms vary by individual health profile and insurer. Speak with a licensed Canadian insurance advisor before making any coverage decision. Reviewed by a licensed Canadian insurance professional.